Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Open-label, Randomized, Parallel-Group, Exploratory Study to Investigate the Effects of Different Doses of S-adenosyl-L-methionine (SAMe) in Subjects With Nonalcoholic Steatohepatitis (NASH) and Non-treated Matched Healthy Volunteers as Control Group

NCT01754714 is registered in ClinicalTrials.gov with Abbott as lead sponsor.

NCT NCT01754714
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01754714 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Open-label, Randomized, Parallel-Group, Exploratory Study to Investigate the Effects of Different Doses of S-adenosyl-L-methionine (SAMe) in Subjects With Nonalcoholic Steatohepatitis (NASH) and Non-treated Matched Healthy Volunteers as Control Group
Lead sponsor
Abbott
Phase
Phase 3
Overall status
Completed
Start date
December 31, 2012
Completion date
September 30, 2014
Enrollment
108 (actual)
Sites
32

Conditions

As the registry lists them; a condition with its own page is linked.

non alcoholic fatty liver disease